Literature DB >> 18406486

Constrained action selection in children with developmental coordination disorder.

Lewis Pettit1, Jennifer Charles, Andrew D Wilson, Mandy S Plumb, Anne Brockman, Justin H G Williams, Mark Mon-Williams.   

Abstract

The effect of advance ('precue') information on short aiming movements was explored in adults, high school children, and primary school children with and without developmental coordination disorder (n=10, 14, 16, 10, respectively). Reaction times in the DCD group were longer than in the other groups and were more influenced by the extent to which the precue constrained the possible action space. In contrast, reaction time did not alter as a function of precue condition in adults. Children with DCD showed greater inaccuracy of response (despite the increased RT). We suggest that the different precue effects reflect differences in the relative benefits of priming an action prior to definitive information about the movement goal. The benefits are an interacting function of the task and the skill level of the individual. Our experiment shows that children with DCD gain a benefit from advance preparation in simple aiming movements, highlighting their low skill levels. This result suggests that goal-directed RTs may have diagnostic potential within the clinic.

Entities:  

Mesh:

Year:  2008        PMID: 18406486     DOI: 10.1016/j.humov.2008.02.014

Source DB:  PubMed          Journal:  Hum Mov Sci        ISSN: 0167-9457            Impact factor:   2.161


  2 in total

1.  Children and older adults exhibit distinct sub-optimal cost-benefit functions when preparing to move their eyes and hands.

Authors:  Claudia C Gonzalez; Mark Mon-Williams; Melanie R Burke
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

2.  Unimanual and bimanual motor performance in children with developmental coordination disorder (DCD) provide evidence for underlying motor control deficits.

Authors:  Melody N Grohs; Rachel L Hawe; Sean P Dukelow; Deborah Dewey
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.